Mon, April 3, 2023

Etzer Darout Downgraded (YMAB) to Hold on, Apr 3rd, 2023

Etzer Darout of Guggenheim, Downgraded "Y-mAbs Therapeutics, Inc." (YMAB) to Hold on, Apr 3rd, 2023.

Etzer has made no other calls on YMAB in the last 4 months.



There are 4 other peers that have a rating on YMAB. Out of the 4 peers that are also analyzing YMAB, 2 agree with Etzer's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alec Stranahan of "B of A Securities" Maintained at Hold and Held Target at $6 on, Saturday, April 1st, 2023
  • Joseph Thome of "Cowen & Co." Downgraded from Buy to Hold on, Thursday, January 5th, 2023


These are the ratings of the 2 analyists that currently disagree with Etzer


  • William Maughan of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $18 on, Friday, March 31st, 2023
  • Michael Ulz of "Morgan Stanley" Downgraded from Hold to Sell on, Friday, January 27th, 2023